The association of polymorphisms in the steroid 5α-reductase type II (SRD5A2) gene with prostate cancer risk in the high altitude mestizo Ecuadorian population was studied in 2009 by Paz-y-Miño et al. [24]. This evidence concerns the gene SRD5A2 and prostate cancer.